ResMed | RMD - Cost Of Sales



ResMed reported $541.36M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Ansell USD 254.1M 232.2M Jun/2024
AtriCure USD 34.66M 3.66M Jun/2025
Baxter International USD 1.82B 55M Jun/2025
Cochlear AUD 290.1M 20.2M Dec/2024
Cooper Companies USD 368.3M 45.1M Jul/2025
CSL USD 3.93B 527M Dec/2024
Dexcom USD 468.3M 21.3M Jun/2025
Edwards Lifesciences USD 344.4M 42.8M Jun/2025
Fisher Paykel Healthcare NZD 193.8M 168.7M Mar/2025
Globus Medical USD 278.95M 83.56M Jun/2025
Haemonetics USD 140.93M 3.38M Jun/2025
Hologic USD 447.2M 2.6M Jun/2025
Idexx Laboratories USD 414.72M 39.68M Jun/2025
Insulet USD 196.9M 36.9M Jun/2025
Integra LifeSciences USD 206.27M 38.76M Jun/2025
Intuitive Surgical USD 822.1M 26.4M Jun/2025
Masimo USD 137.6M 400K Jun/2025
Medtronic USD 3.46B 346M Jul/2025
Philips EUR 2.33B 79M Jun/2025
Ramsay Health Care AUD 2.23B 6.3M Dec/2024
ResMed USD 541.36M 16.04M Jun/2025
Sigma Healthcare AUD 1.72B 188.07M Jul/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Steris USD 763.1M 76.22M Jun/2025
Teleflex USD 349.8M 38.57M Jun/2025
Thermo Fisher Scientific USD 6.81B 751M Jun/2025